ReviewBiosensors2025
3D Printing Assisted Wearable and Implantable Biosensors.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease.RSC advances · 2026Review
- From Static to Dynamic: The Convergence of Nanomaterials and 3D/4D Bioprinting for Adaptive Wearable Sports Biosensors.Biosensors · 2026Review
- Biopolymer-Nanoparticle Interactions in 3D-Printing for Biomedical Applications: Advantages, Limitations and Future Perspectives.Polymers · 2026Review
- A Systematic Review of On-Site Rapid Detection Methods for Antibiotic Residues in Aquatic Products (2021-2025).Foods (Basel, Switzerland) · 2026Review
- A Decade of Research at the Intersection of Additive Manufacturing and Wearable Technology: A Bibliometric Analysis (2015-2025).Biosensors · 2026Review
- Hydrogel-Based Monitoring in Perioperative Anesthesia: A Conceptual Review and Translational Perspective.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biosensors have undergone transformative advancements, evolving into sophisticated wearable and implantable devices capable of real-time health monitoring. Traditional manufacturing methods, however, face limitations in scalability, cost, and design complexity, particularly for miniaturized, multifunctional biosensors. The integration of 3D printing technology addresses these challenges by enabling rapid prototyping, customization, and the production of intricate geometries with high precision. This review explores how additive manufacturing techniques facilitate the fabrication of flexible, stretchable, and biocompatible biosensors. By incorporating advanced materials like conductive polymers, nanocomposites, and hydrogels, 3D-printed biosensors achieve enhanced sensitivity, durability, and seamless integration with biological systems. Innovations such as biodegradable substrates and multi-material printing further expand applications in continuous glucose monitoring, neural interfaces, and point-of-care diagnostics. Despite challenges in material optimization and regulatory standardization, the convergence of 3D printing with nanotechnology and smart diagnostics heralds a new era of personalized, proactive healthcare, offering scalable solutions for both clinical and remote settings. This synthesis underscores the pivotal role of additive manufacturing in advancing wearable and implantable biosensor technology, paving the way for next-generation devices that prioritize patient-specific care and real-time health management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.